Compare CSPI & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSPI | VTGN |
|---|---|---|
| Founded | 1968 | 1998 |
| Country | United States | United States |
| Employees | 111 | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 126.8M | 122.1M |
| IPO Year | 1987 | N/A |
| Metric | CSPI | VTGN |
|---|---|---|
| Price | $12.43 | $4.27 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 13.5K | ★ 900.1K |
| Earning Date | 12-05-2025 | 11-13-2025 |
| Dividend Yield | ★ 0.93% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $57,298,000.00 | $721,000.00 |
| Revenue This Year | N/A | $54.26 |
| Revenue Next Year | N/A | $478.23 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.65 | $1.90 |
| 52 Week High | $21.95 | $5.14 |
| Indicator | CSPI | VTGN |
|---|---|---|
| Relative Strength Index (RSI) | 64.60 | 51.99 |
| Support Level | $11.10 | $3.36 |
| Resistance Level | $11.99 | $4.97 |
| Average True Range (ATR) | 0.55 | 0.51 |
| MACD | 0.15 | -0.05 |
| Stochastic Oscillator | 96.02 | 54.49 |
CSP Inc along with its subsidiaries develops and markets IT integration solutions, security products, managed IT services, cloud services, purpose-built network adapters, and high-performance cluster computer systems. The firm operates in two segments namely Technology Solutions, where the company focus on value-added reseller integrated solutions including third-party hardware, software, and technical computer-related consulting, and High-Performance Products segments, where the company design, manufacture and deliver products and services to customers that require specialized cyber security services, networking and signal processing. It generates a majority of its revenue from the Technology Solutions segment. Geographically, the company generates its maximum revenue from the Americas.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.